In this episode of Let’s Talk Rare, we looked back at P4A’s recent trip to Glasgow, where our colleagues, Sam Morrison & Iro Malekou were on the ground for ISPOR activities leading up to ISPOR 2025. They weren’t just observing—they were actively contributing, presenting a poster abstract, connecting with experts, and taking the pulse of what’s shaping the HEOR and rare disease landscape.

We reflected on their experiences: the conversations that stood out, the insights gained from engaging with stakeholders, and the early signals about where health economics is heading in 2025. From lively discussions in the exhibition hall to the themes emerging in scientific sessions, our colleagues returned with a clear sense of the momentum—and the challenges—facing rare disease access.

This episode highlights their key takeaways: what we learned from presenting our work, how the community reacted, and what the atmosphere in Glasgow suggested about the priorities and pressures that will influence ISPOR 2025.

Whether you attended, followed from afar, or simply want an insider’s view of what’s happening in HEOR and rare disease, this recap brings you right into the room.

🎧 Tune in now to hear P4A’s colleagues share their insights from Glasgow—the people they met, the conversations that mattered, and the signals shaping ISPOR 2025.